SHIN POONG PHARMA INC

Shin Poong Pharma Inc. is a manufacturer.

Shin Poong Pharmaceutical Co., Ltd. is a prominent South Korean pharmaceutical company established in 1962. Headquartered in Seoul, South Korea, the company is fundamentally involved in the research, development, manufacturing, and sales of a comprehensive range of pharmaceutical products.

Its primary business activities encompass ethical drugs, over-the-counter (OTC) medications, medical devices, and health functional foods. Shin Poong Pharma has gained international recognition for its significant contributions to global health, notably through the development of innovative treatments such as Pyramax, a co-formulated artemisinin-based combination therapy (ACT) for malaria, which has achieved WHO prequalification.

The company's extensive product portfolio addresses diverse therapeutic areas, including central nervous system disorders, cardiovascular diseases, gastrointestinal conditions, infectious diseases, oncology, and ophthalmology. Shin Poong Pharma is dedicated to enhancing human well-being through ongoing research and development initiatives, striving to deliver high-quality and effective pharmaceutical solutions to both domestic and international markets. The company operates its own manufacturing facilities, ensuring adherence to stringent quality control standards.

Here are some of the products manufactured or sold by SHIN POONG PHARMA INC of South Korea:

* Antipyretic analgesics: Penzal Q Tab., Penzal Tab.

* Cerebral circulation improvement agent: Tanamin Cap.

* Digestive enzyme: Daewonzyme Tab.

* Gout treatment: Allopurinol Tab.

* Hyperlipidemia treatment: Lipil Tab.

* NSAIDs: Pronopin Tab.

* Parkinson's disease treatment: Pergo Tab.

* Anthelmintics: Praziquantel Tab.(Prazitel)

* Raw material medicine: Artemisinin